Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Liabilities and Shareholders Equity (2016 - 2025)

DarioHealth filings provide 14 years of Liabilities and Shareholders Equity readings, the most recent being $110.1 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 7.41% to $110.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $451.7 million, a 7.42% decrease, with the full-year FY2025 number at $110.1 million, down 7.41% from a year prior.
  • Liabilities and Shareholders Equity hit $110.1 million in Q4 2025 for DarioHealth, down from $117.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $137.3 million in Q2 2022 to a low of $96.4 million in Q4 2023.
  • Median Liabilities and Shareholders Equity over the past 5 years was $117.5 million (2021), compared with a mean of $117.6 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 661.22% in 2021 and later decreased 19.13% in 2023.
  • DarioHealth's Liabilities and Shareholders Equity stood at $100.8 million in 2021, then grew by 18.28% to $119.2 million in 2022, then fell by 19.13% to $96.4 million in 2023, then grew by 23.34% to $118.9 million in 2024, then dropped by 7.41% to $110.1 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $110.1 million (Q4 2025), $117.7 million (Q3 2025), and $108.3 million (Q2 2025) per Business Quant data.